263 related articles for article (PubMed ID: 15571486)
1. New drugs for the treatment of attention-deficit/hyperactivity disorder.
Pataki CS; Feinberg DT; McGough JJ
Expert Opin Emerg Drugs; 2004 Nov; 9(2):293-302. PubMed ID: 15571486
[TBL] [Abstract][Full Text] [Related]
2. Current pharmacotherapy of attention deficit hyperactivity disorder.
Reddy DS
Drugs Today (Barc); 2013 Oct; 49(10):647-65. PubMed ID: 24191257
[TBL] [Abstract][Full Text] [Related]
3. New drugs for treatment of attention-deficit/hyperactivity disorder.
Chung B; Suzuki AR; McGough JJ
Expert Opin Emerg Drugs; 2002 Oct; 7(2):269-76. PubMed ID: 15989550
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological management of attention-deficit hyperactivity disorder.
Reeves G; Schweitzer J
Expert Opin Pharmacother; 2004 Jun; 5(6):1313-20. PubMed ID: 15163276
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.
Chan E; Fogler JM; Hammerness PG
JAMA; 2016 May; 315(18):1997-2008. PubMed ID: 27163988
[TBL] [Abstract][Full Text] [Related]
6. [Stimulant and non-stimulant medication in current and future therapy for ADHD].
Franke AG; Konrad A; Lieb K; Huss M
Fortschr Neurol Psychiatr; 2012 Mar; 80(3):130-40. PubMed ID: 21611939
[TBL] [Abstract][Full Text] [Related]
7. Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.
Eiland LS; Bell EA; Erramouspe J
Ann Pharmacother; 2014 Oct; 48(10):1350-5. PubMed ID: 24982313
[TBL] [Abstract][Full Text] [Related]
8. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
9. Treatment of adult ADHD and comorbid disorders.
Young JL
CNS Spectr; 2006 Oct; 11(10 Suppl 11):10-2. PubMed ID: 17712918
[No Abstract] [Full Text] [Related]
10. Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.
Slatkoff J; Greenfield B
Expert Opin Investig Drugs; 2006 Jun; 15(6):649-67. PubMed ID: 16732717
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of ADHD in adults.
Wilens TE
CNS Spectr; 2008 May; 13(5 Suppl 8):11-3. PubMed ID: 18567133
[No Abstract] [Full Text] [Related]
12. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.
Fredriksen M; Halmøy A; Faraone SV; Haavik J
Eur Neuropsychopharmacol; 2013 Jun; 23(6):508-27. PubMed ID: 22917983
[TBL] [Abstract][Full Text] [Related]
14. [Medical treatments of hyperactive child].
Le Heuzey MF
Arch Pediatr; 2004 Jan; 11(1):64-9. PubMed ID: 14700769
[TBL] [Abstract][Full Text] [Related]
15. [New therapeutic options in the treatment of attention deficit/hyperactivity disorder].
Artigas Pallares J
Rev Neurol; 2004 Feb; 38 Suppl 1():S117-23. PubMed ID: 15011165
[TBL] [Abstract][Full Text] [Related]
16. Non-stimulant treatment of attention-deficit/hyperactivity disorder.
Pliszka SR
CNS Spectr; 2003 Apr; 8(4):253-8. PubMed ID: 12679740
[TBL] [Abstract][Full Text] [Related]
17. Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder : clinical approaches and review of current available evidence.
Prasad S; Steer C
Paediatr Drugs; 2008; 10(1):39-47. PubMed ID: 18162007
[TBL] [Abstract][Full Text] [Related]
18. Drugs under investigation for attention-deficit hyperactivity disorder.
Schweitzer JB; Holcomb HH
Curr Opin Investig Drugs; 2002 Aug; 3(8):1207-11. PubMed ID: 12211416
[TBL] [Abstract][Full Text] [Related]
19. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
Biederman J; Spencer T; Wilens T
Int J Neuropsychopharmacol; 2004 Mar; 7(1):77-97. PubMed ID: 14733627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
